MARKET

REVBW

REVBW

Rvltn Bioscnc
NASDAQ
0.0091
+0.0008
+9.64%
Closed 15:39 04/13 EDT
OPEN
0.0088
PREV CLOSE
0.0083
HIGH
0.0093
LOW
0.0088
VOLUME
70.58K
TURNOVER
--
52 WEEK HIGH
0.0218
52 WEEK LOW
0.0055
MARKET CAP
--
P/E (TTM)
-0.0004
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at REVB last week (0406-0410)?
Weekly Report · 19h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 6d ago
Revelation Biosciences announces formation of AKI advisory board
TipRanks · 04/06 13:18
Weekly Report: what happened at REVB last week (0330-0403)?
Weekly Report · 04/06 10:27
Revelation Gemini data show ‘broad effect,’ says Roth Capital
TipRanks · 03/30 19:56
Revelation Biosciences presents additional data from Prime Clinical Study
TipRanks · 03/30 13:21
Revelation Biosciences Presents Additional Data Analysis From PRIME Study At International Conference On AKI & CRRT 2026
Benzinga · 03/30 13:02
Revelation Biosciences says Gemini normalizes inflammation in PRIME study CKD patients
Reuters · 03/30 13:02
More
About REVBW
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVBW stock methods without spending real money on the virtual paper trading platform.